, Volume 3, Issue 6, pp 495-506

Long-term medical treatment for Parkinson’s disease

Rent the article at a discount

Rent now

* Final gross prices may vary according to local VAT.

Get Access

Opinion statement

The authors of this paper view Parkinson’s disease (PD) as a clinically defined progressive syndrome of resting limb tremor, bradykinesia, muscle rigidity, and a shuffling unsteady gait that responds well to dopaminergic medications. Parkinson’s disease is a not a single entity, but rather a syndrome with diverse causes, with both genetic and environmental risk factors [1••]. The clinician’s concern is to rule out other entities, especially those having another specific treatment, and to give PD patients the best short- and long-term benefit, with the least possible unwanted side effects.